Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03245268 · ClinicalTrials.gov registry record
International BPA Registry
A clinical trial, sponsored by International CTEPH Association.
- Completed
- Registry status
- 500
- Enrollment target
NCT03245268: Completed study, sponsored by International CTEPH Association.
NCT03245268 is a clinical trial that has completed, run by International CTEPH Association. The registered enrollment target is 500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03245268 has completed, sponsored by International CTEPH Association.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
Study Summary
The International Balloon Pulmonary Angioplasty (BPA) Registry is a prospective, multi-center, long-term observational project. Scheduled to start data collection in Q4 2017, the registry will run for approximately four years with a follow-up time for each patient of at least two years. Its primary objective is to investigate the efficacy and safety of BPA intervention in patients with chronic thromboembolic pulmonary hypertension (CTEPH) not amenable to pulmonary endarterectomy (PEA).
Interventions
- PROCEDURE Balloon pulmonary angioplasty
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2018-03-02 |
| Est. Completion | 2022-03-31 |
What the finished NCT03245268 record still lists
NCT03245268 is an observational study that tracks outcomes without assigning an intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Balloon pulmonary angioplasty is the first listed.
NCT03245268 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03245268 about?
NCT03245268 is a clinical study titled "International BPA Registry". The International Balloon Pulmonary Angioplasty (BPA) Registry is a prospective, multi-center, long-term observational project. Scheduled to start data collection in Q4 2017, the registry will run for approximately four years with a follow-up time for each patient of at least two years. Its primary ...
What is the current status of trial NCT03245268?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2018-03-02. Estimated completion is 2022-03-31.
What interventions are being tested in trial NCT03245268?
The interventions under investigation include: Balloon pulmonary angioplasty (PROCEDURE).
Who is sponsoring clinical trial NCT03245268?
This trial is sponsored by International CTEPH Association, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI